Tony Hunter Celebration
When: February 21, 2025
Where: Salk Institute
Preliminary Schedule:
9:00 a.m. | Registration begins |
10:00 a.m. | Opening remarks – Gerald Joyce, President, Salk Institute |
10:10 a.m. | Lew Cantley, Harvard Medical School The discovery of PI-3 kinase and how tyrosine phosphorylation leads to PI-3 kinase signaling, and the development of PI-3 kinase inhibitors as cancer drugs |
10:50 a.m. | Susan Taylor, UC San Diego How elucidating the structure of the protein kinase A catalytic domain has enabled the development of selective kinase inhibitors |
11:30 a.m. | Sara Courtneidge, Oregon Health and Science University Form the discovery that SRC is a membrane protein to its role in cell invasion through activating invadosome function |
12:10 p.m. | Martine Roussel, St. Jude Children’s Research Hospital From Erb, Mac and Myb to CDK inhibitors and medulloblastoma mechanisms and new targeted therapies |
1:00 p.m. | Lunch |
2:00 p.m. | Jon Cooper, Fred Hutchinson Cancer Center From using 2D gels to identify tyrosine kinase substrates to studies of how CAS tyrosine phosphorylation regulates focal adhesion assembly |
2:35 p.m. | Ruth Palmer, University of Gothenburg What model organisms have taught us about the role of the ALK receptor tyrosine kinase in human neuroblastoma |
3:10 p.m. | John Brognard, National Cancer Institute Tracking down the elusive dark kinome to identify new cancer drug targets |
3:45 p.m. | Sean Yamada-Hunter, Stanford University From purifying antibodies in the Hunter lab to becoming a protein engineer who develops novel CAR T cells |
4:05 p.m. | Reuben Shaw, Cancer Center Director, Salk Institute The 50-year history of the Salk Cancer Center and the discoveries its scientists have made that have led to new cancer drugs |
4:40 p.m. | Tony Hunter, Salk Institute Perspectives on the science that Salk has enabled me to do over the past 50 years and where it has led |
5:15 p.m. | Closing remarks – Jan Karlseder, Chief Science Officer, Salk Institute |
5:30 p.m. | Reception |
Please RSVP below by January 17, 2025.
You’re invited to honor and celebrate Professor Tony Hunter by joining us for an engaging and inspiring day of science and camaraderie. Professor Hunter has dedicated 50 years to cancer research at the Salk Institute—an extraordinary career that has led to targeted cancer therapies, saved countless lives, and forever changed how we view human biology.